ELK4 Human Pre-designed siRNA Set A contains three designed siRNAs for ELK4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELL Human Pre-designed siRNA Set A contains three designed siRNAs for ELL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELL2 Human Pre-designed siRNA Set A contains three designed siRNAs for ELL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELL3 Human Pre-designed siRNA Set A contains three designed siRNAs for ELL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ellagic acid-13C12 is 13 C-labeled Ellagic acid (HY-B0183). Ellagic acid is a natural antioxidant and acts as a potent and ATP-competitive inhibitor of CK2 and SHP2, with an IC50 of 40 nM and a Ki of 20 nM[1][2].

ELMO1 Human Pre-designed siRNA Set A contains three designed siRNAs for ELMO1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELMO2 Human Pre-designed siRNA Set A contains three designed siRNAs for ELMO2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELMO3 Human Pre-designed siRNA Set A contains three designed siRNAs for ELMO3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELMOD1 Human Pre-designed siRNA Set A contains three designed siRNAs for ELMOD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELMOD2 Human Pre-designed siRNA Set A contains three designed siRNAs for ELMOD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELN Human Pre-designed siRNA Set A contains three designed siRNAs for ELN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELOA Human Pre-designed siRNA Set A contains three designed siRNAs for ELOA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELOB Human Pre-designed siRNA Set A contains three designed siRNAs for ELOB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELOC Human Pre-designed siRNA Set A contains three designed siRNAs for ELOC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELOF1 Human Pre-designed siRNA Set A contains three designed siRNAs for ELOF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELOVL1 Human Pre-designed siRNA Set A contains three designed siRNAs for ELOVL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELOVL2 Human Pre-designed siRNA Set A contains three designed siRNAs for ELOVL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELOVL3 Human Pre-designed siRNA Set A contains three designed siRNAs for ELOVL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELOVL4 Human Pre-designed siRNA Set A contains three designed siRNAs for ELOVL4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELOVL5 Human Pre-designed siRNA Set A contains three designed siRNAs for ELOVL5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELOVL6 Human Pre-designed siRNA Set A contains three designed siRNAs for ELOVL6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELOVL7 Human Pre-designed siRNA Set A contains three designed siRNAs for ELOVL7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELP1 Human Pre-designed siRNA Set A contains three designed siRNAs for ELP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELP2 Human Pre-designed siRNA Set A contains three designed siRNAs for ELP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELP3 Human Pre-designed siRNA Set A contains three designed siRNAs for ELP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELP4 Human Pre-designed siRNA Set A contains three designed siRNAs for ELP4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELP5 Human Pre-designed siRNA Set A contains three designed siRNAs for ELP5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELP6 Human Pre-designed siRNA Set A contains three designed siRNAs for ELP6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ELQ-596 is a quinolone derivative, that exhibits antimicrobial activity against several protozoan parasites, including the intraerythrocytic parasites Plasmodium and Babesia. ELQ-596 attenuates babesiosis in immunosuppressed mice[1].

ELQ-598, as a prodrug, is converted into the active drug ELQ-596 upon oral administration. ELQ-598 demonstrates potent parasitic growth inhibition capabilities (IC50= 37 nM). ELQ-598 also shows low toxicity towards human cells (IC50= 19 μM). ELQ-598 can be used for research into babesiosis[1].

ELQ-650 is a quinolone derivative, that exhibits antimicrobial activity against several protozoan parasites, including the intraerythrocytic parasites Plasmodium and Babesia. ELQ-650 attenuates babesiosis in immunosuppressed mice[1].

Elsinochrome A is a perylene quinone photosensitizer, and can generate reactive oxygen species (ROS) to induce apoptosis and autophagy under light excitation. Elsinochrome A also shows antifungal activity against C. albicans biofilm through photodynamic antimicrobial chemotherapy (PACT). Elsinochrome A can be used for research of photodynamic therapy (PDT) (Ex: 460 nm)[1][2].

Elubiol (Dichlorophenyl imidazoldioxolan) has moderate sebum-inhibiting activity and can be used in the treatment of oily skin or dandruff[1].

Emamectin (Benzoate) (Standard) is the analytical standard of Emamectin (Benzoate). This product is intended for research and analytical applications. Emamectin Benzoate (MK-244) is an orally active nervoussystem toxicant by binding g-aminobutyric (GABA) receptor in insects. Emamectin Benzoate is one of semi-synthetic derivative of Avermectin (HY-15311) with a broadspectrum of insecticidal and acaricidal activity. Emamectin Benzoate […]

EMB Human Pre-designed siRNA Set A contains three designed siRNAs for EMB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EMC1 Human Pre-designed siRNA Set A contains three designed siRNAs for EMC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EMC10 Human Pre-designed siRNA Set A contains three designed siRNAs for EMC10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EMC2 Human Pre-designed siRNA Set A contains three designed siRNAs for EMC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EMC3 Human Pre-designed siRNA Set A contains three designed siRNAs for EMC3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EMC4 Human Pre-designed siRNA Set A contains three designed siRNAs for EMC4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EMC6 Human Pre-designed siRNA Set A contains three designed siRNAs for EMC6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.